Abstract:palliatives, and nurses in a patient-centered process (8)(9)(10)(11)(12). It is the only way to provide cuYing-edge treatments, balancing benefits, risks, and costs in light of the latest evidence. Following the considerations above, this editorial introduces a collection of articles entitled: "Advances and Challenges in Colorectal Cancer Research and Treatment," which deeply explores the actual complexity of research and clinical practice for CRC patients.In such a heterogeneous scenario, we have merged preclinical and clinical research on CRC, aiming to outline a single fil-rouge. Progress is driven by hyper-specialized research activity, but interconnection among different specialists is crucial for translating discoveries into clinical practice. Considering the latest innovations in each field, a multidisciplinary approach is essential to integrate them into the best clinical solution. For instance, medical and surgical oncologists strongly demand new biomarkers to guide their daily clinical decisions reliably (1,(13)(14)(15)). The answer will likely be found by combining the results of genetic, radiomic, pathologic, and preclinical studies ongoing worldwide (16)(17)(18). This is the spirit of the present special issue, in which the reader will navigate through the most recent advances and challenges in CRC research and treatment, always perceiving a unique aim: to build a multidisciplinary benchmark to answer clinical questions. Here are some of the most relevant insights from the published articles.This study is critical for optimizing clinical outcomes and resource allocation, underscoring the importance of economic considerations in modern clinical reasoning (20)(21)(22).At the same time, as reported by Zhang et al, the most recent laboratory researches, ranging from circulating biomarkers to single-cell RNA sequencing and bulk RNA transcriptome sequencing, pave the way to new approach to CRC, by unveiling heterogeneous immune landscape and identifying pivotal cell subpopulations associated with prognosis (23).New biomarkers for CRC were also discussed. Lucarelli et al. proposed a potential role for the superior mesenteric vein ectasia in predicting liver metastases from rectal cancer (17), while Wang et al. suggested that serum mannose levels could predict the tumor N staging (24). A deeper knowledge of tumor biology is the basis for new therapeutic targets, which are crucial for developing personalized medicine approaches, and beYer prognostic models (25).The term "Personalized medicine", beside its therapeutic implication, also underscores the need for a patientcentered care. The patients and their relatives should be actively involved in the decision-making process and their feelings and behavior (o life-style) should be considered. According to the study by Gu et al., this remains an unmet need, with several patients not having a dominant role in clinical decision-making (26). This issue is even more relevant in elderly patients: as reported by Huemer, patients aged 70 years or older with metastatic CRC can be effectively treated, but their comorbidities and specific physiological responses to treatment must be considered to find the right balance between efficacy and tolerability of interventions (27)(28)(29). Ding et al. reported in a propensity score matching study the benefit of regional block techniques on postoperative high-grade complications in elderly patients with thoracic and abdominal cancers (30).On the same line, the meta-analysis by Zeng et al. outlined the risk factors for lateral pelvic lymph node metastases in patients with low rectal cancer (31). The non-invasive stratification of risk for nodal metastases is essential to plan treatment and modulate aggressiveness of surgery. Finally, the increasing minimal invasiveness of therapeutic options enhances the access to treatment. Shi et al., using a large database of over 25,000 patients, elucidated the indications for endoscopic treatment of T1N0 tumors, which offers a chance of cure even for frail patients (32).In conclusion, this collection aims to provide a deeper understanding of CRC, offering readers new perspectives on diagnosis, treatment, and patient management. The proposed papers strongly highlight the commitment of the medical and scientific community to improving the lives of patients affected by CRC through rigorous research and innovative solutions. While new complexities are continuously uncovered, the collected manuscripts provide invaluable contributions to shaping the future of CRC treatment.In conclusion, this collection aims to provide a deeper understanding of CRC, giving readers new perspectives concerning diagnosis, treatment, and patient management. From the proposed papers, it emerges with strength the commitment of the medical and scientific community to improve the lives of patients affected by CRC through rigorous research and innovative solutions. Whi -Abstract Truncated-

Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer

Different Treatment Strategies and Molecular Features Between Right-Sided and Left-Sided Colon Cancers

Colorectal Cancer, One Entity or Three

Comprehension of rectosigmoid junction cancer molecular features by comparison to the rectum or sigmoid colon cancer

A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies

Colorectal Cancers: An Update on Their Molecular Pathology

Editorial: Colorectal cancer awareness month 2023: diagnosis, clinical course, and surgical management of metastatic colorectal cancer

Abstract 3112: Colorectum metabolome map revealed etiological and survival heterogeneity in cancers of different subsites: Challenging the proximal versus distal classification

Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer

Colorectal Cancer or Colon and Rectal Cancer?

Retrospective study of prognosis of patients with multiple colorectal carcinomas: synchronous versus metachronous makes the difference

Clinical and prognostic differences between surgically resected right-sided and left-sided colorectal cancer

Abstract PR005: Outcomes in colitis-associated metastatic colorectal cancer and intersection with early-onset and signet ring cell carcinoma

Colitis-associated neoplasia: molecular basis and clinical translation

Colorectal cancer in Crohn’s colitis is associated with advanced tumor invasion and a poorer survival compared with ulcerative colitis: a retrospective dual-center study

Genetic architectures of proximal and distal colorectal cancer are partly distinct

Current perspective on the treatment of advanced/metastatic colorectal cancer

Mutational analysis differentiating sporadic carcinomas from colitis-associated colorectal carcinomas

A Multi-Omics Overview of Colorectal Cancer to Address Mechanisms of Disease, Metastasis, Patient Disparities and Outcomes

Comparative Mutational Analysis of Distal Colon Cancer with Rectal Cancer.

Synchronous colorectal cancers: a review of clinical features, diagnosis, treatment, and prognosis.